 |
||||
|
||||
|
||||
|
||||
|
||||
The Journal of Neuroscience, March 8, 2006, 26(10):2830-2838; doi:10.1523/JNEUROSCI.3344-05.2006
Previous Article | Next Article
Neurobiology of Disease
Differential Contributions of Caenorhabditis elegans Histone Deacetylases to Huntingtin Polyglutamine Toxicity
Emily A. Bates,1,2 Martin Victor,1 Adriana K. Jones,2 Yang Shi,1 andAnne C. Hart1,2 1Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115, and 2Massachusetts General Hospital, Center for Cancer Research, Charlestown, Massachusetts 02129
Correspondence should be addressed to Anne C. Hart, Massachusetts General Hospital Center for Cancer Research, 149-7202 13th Street, Charlestown, MA 02129. Email: hart{at}helix.mgh.harvard.edu
Expansion of a polyglutamine tract in the huntingtin protein causes neuronal degeneration and death in Huntington's disease patients, but the molecular mechanisms underlying polyglutamine-mediated cell death remain unclear. Previous studies suggest that expanded polyglutamine tracts alter transcription by sequestering glutamine rich transcriptional regulatory proteins, thereby perturbing their function. We tested this hypothesis in Caenorhabditis elegans neurons expressing a human huntingtin fragment with an expanded polyglutamine tract (Htn-Q150). Loss of function alleles and RNA interference (RNAi) were used to examine contributions of C. elegans cAMP response element-binding protein (CREB), CREB binding protein (CBP), and histone deacetylases (HDACs) to polyglutamine-induced neurodegeneration. Deletion of CREB (crh-1) or loss of one copy of CBP (cbp-1) enhanced polyglutamine toxicity in C. elegans neurons. Loss of function alleles and RNAi were then used to systematically reduce function of each C. elegans HDAC. Generally, knockdown of individual C. elegans HDACs enhanced Htn-Q150 toxicity, but knockdown of C. elegans hda-3 suppressed toxicity. Neuronal expression of hda-3 restored Htn-Q150 toxicity and suggested that C. elegans HDAC3 (HDA-3) acts within neurons to promote degeneration in response to Htn-Q150. Genetic epistasis experiments suggested that HDA-3 and CRH-1 (C. elegans CREB homolog) directly oppose each other in regulating transcription of genes involved in polyglutamine toxicity. hda-3 loss of function failed to suppress increased neurodegeneration in hda-1/+;Htn-Q150 animals, indicating that HDA-1 and HDA-3 have different targets with opposing effects on polyglutamine toxicity. Our results suggest that polyglutamine expansions perturb transcription of CREB/CBP targets and that specific targeting of HDACs will be useful in reducing associated neurodegeneration.
Key words: Huntington; polyglutamine; HDAC; polyQ; neurodegeneration; CBP
Received Aug. 9, 2005; revised Dec. 21, 2005; accepted Jan. 25, 2006.
Correspondence should be addressed to Anne C. Hart, Massachusetts General Hospital Center for Cancer Research, 149-7202 13th Street, Charlestown, MA 02129. Email: hart{at}helix.mgh.harvard.edu
This article has been cited by other articles:
J. Pallos, L. Bodai, T. Lukacsovich, J. M. Purcell, J. S. Steffan, L. M. Thompson, and J. L. Marsh
Inhibition of specific HDACs and sirtuins suppresses pathogenesis in a Drosophila model of Huntington's disease
Hum. Mol. Genet., December 1, 2008; 17(23): 3767 - 3775.
[Abstract] [Full Text] [PDF]
M. C. K. Leung, P. L. Williams, A. Benedetto, C. Au, K. J. Helmcke, M. Aschner, and J. N. Meyer
Caenorhabditis elegans: An Emerging Model in Biomedical and Environmental Toxicology
Toxicol. Sci., November 1, 2008; 106(1): 5 - 28.
[Abstract] [Full Text] [PDF]
K. Usdin
The biological effects of simple tandem repeats: Lessons from the repeat expansion diseases
Genome Res., July 1, 2008; 18(7): 1011 - 1019.
[Abstract] [Full Text] [PDF]
|
|
|
|
 |
|